AQST Q2 2021 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q2 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15M-29.2% YoY

Gross Profit

$11M70.9% margin

Operating Income

-$7M-42.5% margin

Net Income

-$12M-80.6% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+38.0%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$67M

Total Liabilities

$121M

Stockholders' Equity

-$54M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$22M	-29.2%
Gross Profit	$11M	$18M	-40.0%
Operating Income	-$7M	$395,000	-1749.9%
Net Income	-$12M	-$2M	-429.9%

Revenue Segments

Manufacture and Supply Revenue

$11M82%

Proprietary Product Sales

$2M15%

Co-Development and Research Fees

$456,0003%

Geographic Segments

UNITED STATES

$13M85%

Non-US

$2M15%